Mind Club

Data as of 11.07.2026 · Primary sources linked · NOT INVESTMENT ADVICE

Disease Pipeline Tools Obesity

Obesity

Programs, trials, and reported weight change for obesity and overweight.

Data as of 11.07.2026

All studies

Phentermine And Topiramate

A Study Comparing Multiple Doses of VI-0521 With Placebo and Their Single-agent Constituents for Treatment of Obesity in Adults

VIVUS · Phase 3 · Completed · Enrollment 756

NCT00563368

Participants reaching a weight loss threshold

Participants reaching threshold, %

Source: Cited trial source. The denominator is the source figure, when it states one.

X axis: threshold category. Y axis: participants reaching threshold, %.

6662.139.248.643.346.215.5
≥5%
≥10%
≥15%
≥20%
  • VI-0521 Top
  • VI-0521 Mid
  • TPM 46
  • TPM 92
  • PHEN 7.5
  • PHEN 15
  • Placebo
Show as table
Arm≥5%≥10%≥15%≥20%
VI-0521 Top66%n/rn/rn/r
VI-0521 Mid62.1%n/rn/rn/r
TPM 4639.2%n/rn/rn/r
TPM 9248.6%n/rn/rn/r
PHEN 7.543.3%n/rn/rn/r
PHEN 1546.2%n/rn/rn/r
Placebo15.5%n/rn/rn/r

Not shown

Every selected arm is drawn.